Carey Farquhar, MD, MPH

Professor, Departments of Medicine, Epidemiology and Global Health

 

Dr. Carey Farquhar, MD, MPH, received her MD at Harvard Medical School. She completed a residency and chief residency in internal medicine and a fellowship in infectious disease at the University of Washington, where she also earned a Masters in Public Health. She currently spends approximately 2 months each year in Nairobi and Kisumu mentoring US and Kenyan trainees and conducting research on HIV-discordant couples, HIV partner services, correlates of immunity against HIV-1, and mother-to-child HIV-1 transmission. Ongoing studies explore the provision of partner notification and HIV testing services in a cluster-randomized trial of 18 voluntary counseling and testing sites in Kenya and examine home-based education and HIV testing for male partners of pregnant women. The latter is a randomized clinical trial assessing maternal and child health outcomes that is taking place in Kisumu, Kenya. She has published more than 150 peer-reviewed papers and is the Director of two international training programs (listed above) as well as the UW Internal Medicine Global Health Pathway. Dr. Farquhar teaches 3 courses in the School of Public Health -- AIDS: A Multidisciplinary Approach, the Responsible Conduct of International Research, and the Integrated Residency Global Health Leadership course. In addition, she sees HIV-infected patients one half-day per week at Madison Clinic and attends in the Infectious Disease clinic and on the wards at Harborview Medical Center.

Publications

  1. Bishop, MD, Xu, L, Boyce, CL, Drain, PK, Farquhar, C, Hawes, SE et al.. HIV-1 3΄ polypurine tract mutations and integrase inhibitor resistance. AIDS. 2025;39 (14):1996-2013. doi: 10.1097/QAD.0000000000004315. PubMed PMID:41603872 .
  2. Cosmas, M, Loice, M, William, S, Esther, G, Tecla, T, Carey, F et al.. HIV risk and oral pre-exposure prophylaxis (PrEP) among people who inject drugs (PWID) in Nairobi: a cross-sectional study. BMC Infect Dis. 2026; :. doi: 10.1186/s12879-025-12490-1. PubMed PMID:41492124 .
  3. Doshi, S, Richardson, BA, Nazzinda, R, Mugerwa, H, Bittencourt, MS, Erem, G et al.. The Association of Mild Kidney Disease With Coronary Artery Disease Is Stronger for People Living With HIV. J Acquir Immune Defic Syndr. 2026;101 (1):95-102. doi: 10.1097/QAI.0000000000003765. PubMed PMID:41380171 PubMed Central PMC12703689.
  4. Shah, H, Krishnan, S, Narashim, A, Korir, S, Omondi, G, Maxime Ale, B et al.. Low Prevalence of Coronary Artery Calcium in High Cardiometabolic Risk Kenyan Adults with and Without HIV: The ASANTE Study. Glob Heart. 2025;20 (1):107. doi: 10.5334/gh.1495. PubMed PMID:41356097 PubMed Central PMC12680004.
  5. Beck, IA, Boyce, CL, Bishop, MD, Oldroyd, AR, du Toit, L, Saimen, A et al.. HIV resistance to dolutegravir varies with co-administered agents. Clin Infect Dis. 2025; :. doi: 10.1093/cid/ciaf481. PubMed PMID:40898778 .
Search PubMed

Comments are closed.